Literature DB >> 8563094

Adult T-cell leukemia.

K Takatsuki1.   

Abstract

Adult T-cell leukemia (ATL) was first reported in Japan, where it has a high incidence in the southwestern region. The retrovirus, human T-lymphotropic virus type I (HTLV-I), is the causative agent of ATL. In ATL-endemic areas, the rate of HTLV-I carriers is high. A definite diagnosis of ATL is based on the presence of HTLV-I proviral DNA in the tumor cell DNA. ATL cells originate from the CD4 subset of peripheral T cells. ATL shows diverse clinical features but can be divided into four subtypes:acute, chronic, smoldering, and lymphoma type. Chemotherapy is not effective; the acute and lymphoma types have a poor prognosis. Familial occurrence of ATL is common. HTLV-I infection is caused by transmission of live infected lymphocytes from mother to child, from man to woman, or by blood transfusion. Infection with HTLV-I can lead to other diseases, including HTLV-I-associated myelopathy/tropical spastic paraparesis and HTLV-I uveitis.

Entities:  

Mesh:

Year:  1995        PMID: 8563094     DOI: 10.2169/internalmedicine.34.947

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

Review 1.  Adult T cell leukemia lymphoma.

Authors:  Lee Ratner
Journal:  Front Biosci       Date:  2004-09-01

2.  Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.

Authors:  B Zimmerman; S Niewiesk; M D Lairmore
Journal:  Vet Pathol       Date:  2010-05-04       Impact factor: 2.221

3.  Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.

Authors:  Satsuki Owatari; Maki Otsuka; Kimiharu Uozumi; Taketsugu Takeshita; Shuichi Hanada
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

4.  Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells.

Authors:  Kazuhiro Nagai; Itsuro Jinnai; Tomoko Hata; Tetsuya Usui; Daisuke Sasaki; Kunihiro Tsukasaki; Kazuyuki Sugahara; Yoshitaka Hishikawa; Yasuaki Yamada; Yuetsu Tanaka; Takehiko Koji; Hiroyuki Mano; Shimeru Kamihira; Masao Tomonaga
Journal:  Int J Hematol       Date:  2008-12-02       Impact factor: 2.490

Review 5.  Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.

Authors:  Elaine S Jaffe; Nancy Lee Harris; Harald Stein; Peter G Isaacson
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

6.  Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009.

Authors:  Ina Novak; Ozren Jaksić; Tomislav Kulis; Katarina Batinjan; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

Review 7.  40 years of the human T-cell leukemia virus: past, present, and future.

Authors:  Yutaka Tagaya; Masao Matsuoka; Robert Gallo
Journal:  F1000Res       Date:  2019-02-28

Review 8.  Alternative RNA splicing in cancer: what about adult T-cell leukemia?

Authors:  Julie Tram; Jean-Michel Mesnard; Jean-Marie Peloponese
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

9.  Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels.

Authors:  James M Bogenberger; Paul J Laybourn
Journal:  Retrovirology       Date:  2008-01-31       Impact factor: 4.602

Review 10.  Applying spatial epidemiology to hematological disease using R: a guide for hematologists and oncologists.

Authors:  Kei Kohno; Hiroto Narimatsu; Katsumi Otani; Ri Sho; Yosuke Shiono; Ikuko Suzuki; Yuichi Kato; Akira Fukao; Takeo Kato
Journal:  J Blood Med       Date:  2014-03-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.